Skip to main content
NIH Intramural Research Program, Our Research Changes Lives

Navigation controls

  • Search
  • Menu

Social follow links

  • Podcast
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
      • Nobel Prize
      • Lasker Award
      • Breakthrough Prize
      • Shaw Prize
      • Presidential Early Career Award for Scientists and Engineers (PECASE)
      • Presidential Medal of Freedom
      • National Medal of Science
      • Searle Scholars
      • The National Academy of Sciences
      • The National Academy of Medicine
      • The National Academy of Engineering
      • The American Academy of Arts and Sciences
      • National Medal of Technology & Innovation
      • Samuel J. Heyman Service to America Medals
      • Crafoord Prize
      • Fellows of the Royal Society
      • Canada Gairdner Awards
    • Organization & Leadership
    • Our Programs
      • NCI
      • NEI
      • NHGRI
      • NHLBI
      • NIA
      • NIAAA
      • NIAID
      • NIAMS
      • NIBIB
      • NICHD
      • NIDA
      • NIDCD
      • NIDCR
      • NIDDK
      • NIEHS
      • NIMH
      • NIMHD
      • NINDS
      • NINR
      • NLM
      • CC
      • NCATS
      • NCCIH
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
      • Biomedical Engineering & Biophysics
      • Cancer Biology
      • Cell Biology
      • Chemical Biology
      • Chromosome Biology
      • Clinical Research
      • Computational Biology
      • Developmental Biology
      • Epidemiology
      • Genetics & Genomics
      • Health Disparities
      • Immunology
      • Microbiology & Infectious Diseases
      • Molecular Biology & Biochemistry
      • Molecular Pharmacology
      • Neuroscience
      • RNA Biology
      • Social & Behavioral Sciences
      • Stem Cell Biology
      • Structural Biology
      • Systems Biology
      • Virology
    • Principal Investigators
      • View by Investigator Name
      • View by Scientific Focus Area
    • Accomplishments
      • View All Accomplishments by Date
      • View All Health Topics
      • The Body
      • Health & Wellness
      • Conditions & Diseases
      • Procedures
    • Accelerating Science
      • Investing in Cutting-Edge Animal Models
      • Creating Cell-Based Therapies
      • Advancing Computational and Structural Biology
      • Combating Drug Resistance
      • Developing Novel Imaging Techniques
      • Charting the Pathways of Inflammation
      • Zooming in on the Microbiome
      • Uncovering New Opportunities for Natural Products
      • Stimulating Neuroscience Research
      • Pursuing Precision Medicine
      • Unlocking the Potential of RNA Biology and Therapeutics
      • Producing Novel Vaccines
    • Research in Action
      • View All Stories
      • Battling Blood-Sucking Bugs
      • Unexpected Leads to Curb Addiction
      • Shaping Therapies for Sickle Cell Disease
      • The Mind’s Map Maker
    • Trans-IRP Research Resources
      • Supercomputing
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
      • Get Involved with Clinical Research
      • Physician Resources
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
      • Stadtman Tenure-Track Investigators
        • Science, the Stadtman Way
      • Lasker Clinical Research Scholars
      • Independent Research Scholar
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
I am Intramural Blog

Taming Unruly Stem Cells to Enhance Eye Research

Widely Available Molecule Could Aid Development of Therapies for Blinding Diseases

By Brandon Levy

Tuesday, October 4, 2022

eye

IRP researchers have discovered that a cheap, widely available molecule can help lab-grown stem cells develop into complex, three-dimensional models of the eye’s retina.

As scientists inch closer to growing fully functioning organs outside the body, it’s easy to forget that it’s already possible to grow miniature, simplified versions of some organs in the lab. These ‘organoids’ are an extremely useful research tool, but producing them can be tricky. New IRP research could make it much easier to grow organoids that mimic the eye’s retina, thereby accelerating discoveries about a variety of vision-impairing diseases.1

Retinal organoids are three-dimensional structures with distinct layers containing all the major cell types found in the real human retina, the part of the eye that converts light into electrical signals the brain can interpret. While organoids aren’t perfect models, they are much closer to the real deal than the flat collections of a single cell type that scientists have long used for their experiments.

“A retinal organoid is as close to being a retina in a dish as we’ve ever had,” says IRP senior investigator Tiansen Li, Ph.D., the new study’s senior author.

What’s more, scientists can grow retinal organoids that have the exact same genetic mutations as a patient with an eye disease, enabling them to investigate the biological causes of a person’s specific vision problems. This involves taking skin or blood cells from the patient and turning them into cells called induced pluripotent stem cells (iPSCs), which can develop into any cell type found in the body. These iPSCs can then be grown in unlimited quantities to create ‘cell lines’ with specific properties, and researchers like those in Dr. Li’s lab coax them to develop into retinal organoids by exposing them to specific molecules. Unfortunately, not all cell lines cooperate with the scientists trying to manipulate them.

Human pluripotent stem cells, as seen under a microscope.

“The cell lines that we create from different people can react differently to our process,” says IRP postdoctoral fellow Florian Regent, Ph.D., who led the new study in Dr. Li’s lab. “Our process can be very effective for some cell lines and not for others. And, of course, when you want to study a particular patient’s cell line, you can’t work with a different one — the process has to work with that cell line.”

In the new study, Dr. Li’s team added an additional chemical to their standard process for turning iPSCs into retinal organoids: a form of vitamin B3 called nicotinamide that is commonly found in dietary supplements. The group selected nicotinamide for the experiment because it has previously been used to encourage iPSCs to develop into a different part of the retina, the retinal pigment epithelium (RPE).

At the beginning of their experiment, the IRP researchers exposed stem cells from eight different cell lines to nicotinamide for either eight or twenty one days. Some of the cell lines readily developed into retinal organoids even without the nicotinamide treatment, while others did not. The researchers discovered that the eight-day nicotinamide treatment significantly increased the yield of retinal organoids from all of the cell lines, including those that produced very few organoids in the absence of nicotinamide. The three-week treatment also boosted organoid yields from some of the cell lines, but decreased the yield for one cell line, suggesting that nicotinamide treatment is more beneficial during a specific, narrow developmental window.

“During development, cells are influenced by their intrinsic programs, obviously, but also by external environmental cues,” Dr. Li explains. “These cues act at defined time points, so a cue that does one thing at one point in time, two days later might do the opposite. That applies to nicotinamide as well. If you apply it for an extended duration, it might overstay its welcome.”

These images from the study show how induced pluripotent stem cells develop into retinal organoids over the course of 150 days.

The study also shed light on why nicotinamide encourages iPSCs to develop into retinal organoids. During the early stages of the experiment, the stem cells treated with nicotinamide more readily transformed into an immature form of neural cells capable of eventually becoming retinal cells, as opposed to changing into the sorts of immature cells that could only develop into cell types like skin and bone cells. Moreover, the researchers discovered that nicotinamide-treated cells had lower activity in a set of genes related to bone morphogenic protein (BMP), a molecule that plays an important role in embryonic development. This discovery suggests that inhibition of this BMP-related cellular system is one reason — though likely not the only reason — why nicotinamide helps turn stem cells into retinal organoids.

Dr. Florian Regent (left) and Dr. Tiansen Li (right)

Regardless of how exactly nicotinamide works its magic, Dr. Li believes that it could soon become a standard part of the procedures other labs use to produce retinal organoids. Nicotinamide is cheap and widely available, and by using it to facilitate the creation of retinal organoids from stem cell lines that previously refused to develop into them, scientists could find it much easier to make discoveries about a number of diseases that affect vision.

“We continue to gather data to support the validity of this approach, and our hope and expectation is that the entire field will adopt it, just as they adopted other standardized and widely used additions to retinal organoid production,” Dr. Li says. “I would like to see it used in everybody’s procedures in the next few years. That would make me very happy.”

Subscribe to our weekly newsletter to stay up-to-date on the latest breakthroughs in the NIH Intramural Research Program.

References:

[1] Regent F, Batz Z, Kelley RA, Gieser L, Swaroop A, Chen HY, Li T. Nicotinamide Promotes Formation of Retinal Organoids From Human Pluripotent Stem Cells via Enhanced Neural Cell Fate Commitment. Front Cell Neurosci. 2022 Jun 17;16:878351. doi: 10.3389/fncel.2022.878351.


Category: IRP Discoveries
Tags: neuroscience, stem cells, eyes, vision

Related Blog Posts

  • Experimental Treatment Helps Neurons Recover From Damage
  • Pain Research Center Accelerates IRP Pain Studies
  • Tiny Molecules Have Big Potential for Treating Eye Diseases
  • Translating Genetic Findings Into Dementia Treatments
  • Antiviral Drug Stems the Spread of Parkinson’s-Promoting Protein

This page was last updated on Wednesday, May 24, 2023

Blog menu

  • Contributing Authors
    • Anindita Ray
    • Brandon Levy
    • Devon Valera
    • Melissa Glim
  • Categories
    • IRP Discoveries
    • Profiles
    • Events
    • NIH History
    • IRP Life

Blog links

  • Subscribe to RSS feed

Get IRP Updates

Subscribe

  • Email
  • Print
  • Share Twitter Facebook LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
    • Organization & Leadership
    • Our Programs
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
    • Principal Investigators
    • Accomplishments
    • Accelerating Science
    • Research in Action
    • Trans-IRP Research Resources
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Clinical Faculty
    • Advancing Translational Science
    • Clinical Trials
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
  • Department of Health and Human Services
  • National Institutes of Health
  • USA.gov

Footer

  • Home
  • Contact Us
  • IRP Brand Materials
  • HHS Vulnerability Disclosure
  • Web Policies & Notices
  • Site Map
  • Search